These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14678800)

  • 21. [Muscular dystrophy due to a deficit of gamma-sarcoglycan. A report of three patients with the Delta-521t mutation].
    Eirís-Puñal J; Pintos-Martínez E; Lasa A; Gallano P; Castro-Gago M
    Rev Neurol; 2002 Mar 1-15; 34(5):486-9. PubMed ID: 12040521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation.
    McNally EM; Passos-Bueno MR; Bönnemann CG; Vainzof M; de Sá Moreira E; Lidov HG; Othmane KB; Denton PH; Vance JM; Zatz M; Kunkel LM
    Am J Hum Genet; 1996 Nov; 59(5):1040-7. PubMed ID: 8900232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH; Barresi R; Campbell KP
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy.
    McNally EM; Duggan D; Gorospe JR; Bönnemann CG; Fanin M; Pegoraro E; Lidov HG; Noguchi S; Ozawa E; Finkel RS; Cruse RP; Angelini C; Kunkel LM; Hoffman EP
    Hum Mol Genet; 1996 Nov; 5(11):1841-7. PubMed ID: 8923014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E).
    Bönnemann CG; Passos-Bueno MR; McNally EM; Vainzof M; de Sá Moreira E; Marie SK; Pavanello RC; Noguchi S; Ozawa E; Zatz M; Kunkel LM
    Hum Mol Genet; 1996 Dec; 5(12):1953-61. PubMed ID: 8968749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.
    Porter JD; Merriam AP; Hack AA; Andrade FH; McNally EM
    Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.
    Crosbie RH; Lim LE; Moore SA; Hirano M; Hays AP; Maybaum SW; Collin H; Dovico SA; Stolle CA; Fardeau M; Tomé FM; Campbell KP
    Hum Mol Genet; 2000 Aug; 9(13):2019-27. PubMed ID: 10942431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.
    Politano L; Nigro V; Passamano L; Petretta V; Comi LI; Papparella S; Nigro G; Rambaldi PF; Raia P; Pini A; Mora M; Giugliano MA; Esposito MG; Nigro G
    Neuromuscul Disord; 2001 Mar; 11(2):178-85. PubMed ID: 11257475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic heterogeneity within a consanguineous family involving the LGMD 2D and the LGMD 2C genes.
    Fendri K; Kefi M; Hentati F; Amouri R
    Neuromuscul Disord; 2006 May; 16(5):316-20. PubMed ID: 16616845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?
    Klinge L; Dekomien G; Aboumousa A; Charlton R; Epplen JT; Barresi R; Bushby K; Straub V
    Neuromuscul Disord; 2008 Dec; 18(12):934-41. PubMed ID: 18996010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population.
    Vainzof M; Passos-Bueno MR; Pavanello RC; Marie SK; Oliveira AS; Zatz M
    J Neurol Sci; 1999 Mar; 164(1):44-9. PubMed ID: 10385046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer.
    Cordier L; Hack AA; Scott MO; Barton-Davis ER; Gao G; Wilson JM; McNally EM; Sweeney HL
    Mol Ther; 2000 Feb; 1(2):119-29. PubMed ID: 10933922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant deficiency of beta- and gamma-sarcoglycans in 20 alpha-sarcoglycan (adhalin)-deficient patients: immunohistochemical analysis and clinical aspects.
    Barresi R; Confalonieri V; Lanfossi M; Di Blasi C; Torchiana E; Mantegazza R; Jarre L; Nardocci N; Boffi P; Tezzon F; Pini A; Cornelio F; Mora M; Morandi L
    Acta Neuropathol; 1997 Jul; 94(1):28-35. PubMed ID: 9224527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency of the 50 kDa dystrophin-associated-glycoprotein (adhalin) in an Indian autosomal recessive limb girdle muscular dystrophy patient : immunochemical analysis and clinical aspects.
    Handa V; Mital A; Gupta M; Goyle S
    Neurol India; 2001 Mar; 49(1):19-24. PubMed ID: 11303236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sarcoglycanopathies, a particular limb-girdle muscular dystrophy type (phenotype in three Polish families): initial report].
    Dorobek M; Fidziańska-Dolot A
    Neurol Neurochir Pol; 2002; 36(6):1095-105. PubMed ID: 12715687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical spectrum of sarcoglycanopathies.
    Angelini C; Fanin M; Freda MP; Duggan DJ; Siciliano G; Hoffman EP
    Neurology; 1999 Jan; 52(1):176-9. PubMed ID: 9921870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene.
    Nigro V; de Sá Moreira E; Piluso G; Vainzof M; Belsito A; Politano L; Puca AA; Passos-Bueno MR; Zatz M
    Nat Genet; 1996 Oct; 14(2):195-8. PubMed ID: 8841194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different manners of sarcoglycan expression in genetically proven alpha-sarcoglycan deficiency and gamma-sarcoglycan deficiency.
    Higuchi I; Kawai H; Umaki Y; Kawajiri M; Adachi K; Fukunaga H; Nakagawa M; Arimura K; Osame M
    Acta Neuropathol; 1998 Aug; 96(2):202-6. PubMed ID: 9705137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice.
    Sasaoka T; Imamura M; Araishi K; Noguchi S; Mizuno Y; Takagoshi N; Hama H; Wakabayashi-Takai E; Yoshimoto-Matsuda Y; Nonaka I; Kaneko K; Yoshida M; Ozawa E
    Neuromuscul Disord; 2003 Mar; 13(3):193-206. PubMed ID: 12609501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.